| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |